2016-03-05T00:00:00.000-05:00
strong buy rating,0.369479
price target,0.407415
business’s stock,-0.234225
recent analyst reports,-0.212643
research analysts,-0.214284
midday trading,-0.382952
stock,0.0544171
Tuttle Investment Counsel,0.369963
recent filing,0.351443
Equities research analysts,-0.214284
InvestorPlace Broker Center,0.555736
biopharmaceutical company,0.642682
personal trading style,0.598412
research-based biopharmaceutical company,0.642682
average rating,-0.309537
Gilead Sciences Inc.,0.555178
Investment Counsel LLC,0.369963
average price,0.1136
shares,-0.248504
consensus estimate,0.470552
concise daily summary,0.447788
consensus target price,0.437056
Gilead Sciences,0.127244
GILD,-0.212643
stock broker,0.245696
Macguire Cheswick,0.369963
John C. Martin,-0.203608
chronic hepatitis,-0.646567
EVP Paul Rutherford,-0.264841
quarter,-0.351682
